Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.73M Buy
40,000
+39,800
+19,900% +$4.59M ﹤0.01% 2893
2026
Q1
$23.9K Buy
+200
New +$26.2K ﹤0.01% 5705
2025
Q3
Sell
-300
Closed -$38.8K 7444
2025
Q2
$38.8K Buy
+300
New +$36.3K ﹤0.01% 5596

Other funds holding XYL

Wells Fargo's XYL Position: Q2 2026 in Review

Wells Fargo reduced its Xylem (XYL) stake by 7.2% in Q2 2026, selling an estimated $16.5M and leaving 1,839,680 shares worth $217M. The position accounts for 0.04% of the portfolio, ranked #403.

Wells Fargo first reported a position in XYL in Q2 2013 and has held it in 53 quarters since. The position peaked at $293M in Q3 2025. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Wells Fargo held 1,839,680 shares of Xylem worth $217M as of Q2 2026.
  • Wells Fargo sold 143,248 Xylem shares in Q2 2026, an estimated $16.5M.
  • Xylem made up 0.04% of Wells Fargo's portfolio in Q2 2026, its #403 holding.
  • Wells Fargo first reported a position in Xylem in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Xylem position peaked at $293M in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.